Integrated Summary of Effectiveness
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 8, 2015
February 25, 2022
dceeebd6-6607-4d3c-beb9-417012c9a968
Related Documents
Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry
Guidance DocumentAugust 5, 2020Center for Drug Evaluation and Research
Q14 Analytical Procedure Development
Guidance DocumentMarch 7, 2024Center for Drug Evaluation and Research
M12 Drug Interaction Studies
Guidance DocumentAugust 2, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.